Three Battles to Watch in the 1990s

HOWEVER the debate on national health care reform comes out, and whatever strategies are eventually used to achieve the seemingly incompatible goals of providing universal access, improving quality, and controlling costs, one thing is certain: The day-to-day decisions of those who actually provide health care will be put under ever-increasing stress. Reform will not solve the problems that have been causing the pressure on physician decision making over the last decade; it will rely on further pressure to solve the problems. We know this will occur for several reasons. Begin with the fact that of the three main goals of health care reform— access, quality, and cost—the driving force is cost. To be more precise, the driving force is the rate of increase in costs—the fact that health care costs have been rising at about twice the rate of inflation. It is this feature of health care that has transformed

[1]  F. Iber,et al.  Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis , 1992 .

[2]  J Drago,et al.  The American cancer society national prostate cancer detection project. Findings on the detection of early prostate cancer in 2425 men , 1991, Cancer.

[3]  A. Detsky,et al.  Evidence-based medicine. A new approach to teaching the practice of medicine. , 1992, JAMA.

[4]  L. Baker,et al.  Breast cancer detection demonstration project: Five‐year summary report , 1982, CA: a cancer journal for clinicians.

[5]  A. Miller,et al.  Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[6]  Y Pawitan,et al.  Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators. , 1991, The American journal of cardiology.

[7]  David M. Eddy,et al.  Practice Policies—Guidelines for Methods , 1990 .

[8]  Eugene R. Schiff,et al.  Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa , 1989 .

[9]  Neil R. Miller,et al.  A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis , 1992 .

[10]  David M. Eddy,et al.  Applying Cost-effectiveness Analysis: The Inside Story , 1992 .

[11]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[12]  D M Eddy Clinical decision making: from theory to practice. Designing a practice policy. Standards, guidelines, and options. , 1990, JAMA.

[13]  M. Barry,et al.  A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. , 1993, JAMA.

[14]  S. Woolf,et al.  Evidence-based practice guidelines from the US Preventive Services Task Force. , 1993, JAMA.

[15]  G. Friedman,et al.  A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. , 1992, The New England journal of medicine.

[16]  G. Lundberg American health care system management objectives. The aura of inevitability becomes incarnate. , 1993, JAMA.

[17]  S. Winawer Colorectal cancer screening comes of age. , 1993, The New England journal of medicine.

[18]  D. Andrulis,et al.  Assessing medical technologies. , 1978, Bulletin of the New York Academy of Medicine.